SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome

References

• Oka D, Yamashita S, Tomioka T, Nakanishi Y, Kato H, Kaminishi M, Ushijima T. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers. Cancer 2009; 115:3412 - 3426
   PubMed Web of Science ®Google Scholar
• Yu C, Chen K, Zheng H, Guo X, Jia W, Li M, Zeng M, Li J, Song L. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 2009; 30:894 - 901
   PubMed Web of Science ®Google Scholar
• Xue H, Lu B, Lai M. The cancer secretome: a reservoir of biomarkers. J Transl Med 2008; 6:52
   PubMed Web of Science ®Google Scholar
• Zhang W, Matrisian LM, Holmbeck K, Vick CC, Rosenthal EL. Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo. BMC Cancer 2006; 6:52
   PubMed Web of Science ®Google Scholar
• Pellitteri-Hahn MC, Warren MC, Didier DN, Winkler EL, Mirza SP, Greene AS, Olivier M. Improved mass spectrometric proteomic profiling of the secretome of rat vascular endothelial cells. J Proteome Res 2006; 5:2861 - 2864
   PubMed Web of Science ®Google Scholar
• Chevallet M, Diemer H, Van Dorssealer A, Villiers C, Rabilloud T. Toward a better analysis of secreted proteins: the example of the myeloid cells secretome. Proteomics 2007; 7:1757 - 1770
   PubMed Web of Science ®Google Scholar
• Kratchmarova I, Kalume DE, Blagoev B, Scherer PE, Podtelejnikov AV, Molina H, et al. A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 2002; 1:213 - 222
   PubMed Web of Science ®Google Scholar
• Liu J, Hong Z, Ding J, Liu J, Zhang J, Chen S. Predominant release of lysosomal enzymes by newborn rat microglia after LPS treatment revealed by proteomic studies. J Proteome Res 2008; 7:2033 - 2049
   PubMed Web of Science ®Google Scholar
• An E, Lu X, Flippin J, Devaney JM, Halligan B, Hoffman EP, et al. Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors. J Proteome Res 2006; 5:2599 - 2610
   PubMed Web of Science ®Google Scholar
• Mathias RA, Wang B, Ji H, Kapp EA, Moritz RL, Zhu HJ, Simpson RJ. Secretome-based proteomic profiling of Ras-transformed MDCK cells reveals extracellular modulators of epithelial-mesenchymal transition. J Proteome Res 2009; 8:2827 - 2837
   PubMed Web of Science ®Google Scholar
• Gronborg M, Kristiansen TZ, Iwahori A, Chang R, Reddy R, Sato N, et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 2006; 5:157 - 171
   PubMed Web of Science ®Google Scholar
• Wu HY, Chang YH, Chang YC, Liao PC. Proteomics analysis of nasopharyngeal carcinoma cell secretome using a hollow fiber culture system and mass spectrometry. J Proteome Res 2009; 8:380 - 389
   PubMed Web of Science ®Google Scholar
• Iannetti A, Pacifico F, Acquaviva R, Lavorgna A, Crescenzi E, Vascotto C, et al. The neutrophil gelatinase-associated lipocalin (NGAL), a NFkappaB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc Natl Acad Sci USA 2008; 105:14058 - 14063
   PubMed Web of Science ®Google Scholar
• Zhong L, Roybal J, Chaerkady R, Zhang W, Choi K, Alvarez CA, et al. Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment. Cancer Res 2008; 68:7237 - 7245
   PubMed Web of Science ®Google Scholar
• Weng LP, Wu CC, Hsu BL, Chi LM, Liang Y, Tseng CP, et al. Secretome-based identification of Mac-2 binding protein as a potential oral cancer marker involved in cell growth and motility. J Proteome Res 2008; 7:3765 - 3775
   PubMed Web of Science ®Google Scholar
• Kobayashi R, Deavers M, Patenia R, Rice-Stitt T, Halbe J, Gallardo S, Freedman RS. 14-3-3 zeta protein secreted by tumor associated monocytes/macrophages from ascites of epithelial ovarian cancer patients. Cancer Immunol Immunother 2009; 58:247 - 258
   PubMed Web of Science ®Google Scholar
• Wu CC, Chen HC, Chen SJ, Liu HP, Hsieh YY, Yu CJ, et al. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics 2008; 8:316 - 332
   PubMed Web of Science ®Google Scholar
• Dombkowski AA, Cukovic D, Novak RF. Secretome analysis of microarray data reveals extracellular events associated with proliferative potential in a cell line model of breast disease. Cancer Lett 2006; 241:49 - 58
   PubMed Web of Science ®Google Scholar
• Paulitschke V, Kunstfeld R, Mohr T, Slany A, Micksche M, Drach J, et al. Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells. J Proteome Res 2009; 8:2501 - 2510
   PubMed Web of Science ®Google Scholar
• Du XL, Hu H, Lin DC, Xia SH, Shen XM, Zhang Y, et al. Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma. J Mol Med 2007; 85:863 - 875
   PubMed Web of Science ®Google Scholar
• Fu L, Qin YR, Xie D, Chow HY, Ngai SM, Kwong DL, et al. Identification of alpha-actinin 4 and 67 kDa laminin receptor as stage-specific markers in esophageal cancer via proteomic approaches. Cancer 2007; 110:2672 - 2681
   PubMed Web of Science ®Google Scholar
• Fujita Y, Nakanishi T, Hiramatsu M, Mabuchi H, Miyamoto Y, Miyamoto A, et al. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma. Clin Cancer Res 2006; 12:6415 - 6420
   PubMed Web of Science ®Google Scholar
• Fujita Y, Nakanishi T, Miyamoto Y, Hiramatsu M, Mabuchi H, Miyamoto A, et al. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma. Cancer Lett 2008; 263:280 - 290
   PubMed Web of Science ®Google Scholar
• Uemura N, Nakanishi Y, Kato H, Saito S, Nagino M, Hirohashi S, Kondo T. Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics. Int J Cancer 2009; 124:2106 - 2115
   PubMed Web of Science ®Google Scholar
• Zhou G, Li H, Gong Y, Zhao Y, Cheng J, Lee P, Zhao Y. Proteomic analysis of global alteration of protein expression in squamous cell carcinoma of the esophagus. Proteomics 2005; 5:3814 - 3821
   PubMed Web of Science ®Google Scholar
• Breton J, Gage MC, Hay AW, Keen JN, Wild CP, Donnellan C, et al. Proteomic screening of a cell line model of esophageal carcinogenesis identifies cathepsin D and aldo-keto reductase 1C2 and 1B10 dysregulation in Barrett's esophagus and esophageal adenocarcinoma. J Proteome Res 2008; 7:1953 - 1962
   PubMed Web of Science ®Google Scholar
• Xu SY, Liu Z, Ma WJ, Sheyhidin I, Zheng ST, Lu XM. New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma. Biomarkers 2009; 14:340 - 346
   PubMed Web of Science ®Google Scholar
• Engwegen JY, Gast MC, Schellens JH, Beijnen JH. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol Sci 2006; 27:251 - 259
   PubMed Web of Science ®Google Scholar
• Ando T, Ishiguro H, Kimura M, Mitsui A, Mori Y, Sugito N, et al. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. Oncol Rep 2007; 18:601 - 609
   PubMed Web of Science ®Google Scholar
• Harsha HC, Molina H, Pandey A. Quantitative proteomics using stable isotope labeling with amino acids in cell culture. Nat Protoc 2008; 3:505 - 516
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Kato H, Nakajima M, Sohda M, Fukai Y, Masuda N, et al. FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer 2003; 89:140 - 145
   PubMed Web of Science ®Google Scholar
• Nishihira T, Hashimoto Y, Katayama M, Mori S, Kuroki T. Molecular and cellular features of esophageal cancer cells. J Cancer Res Clin Oncol 1993; 119:441 - 449
   PubMed Web of Science ®Google Scholar
• Terashita Y, Sasaki H, Haruki N, Nishiwaki T, Ishiguro H, Shibata Y, et al. Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer. Jpn J Clin Oncol 2002; 32:238 - 243
   PubMed Web of Science ®Google Scholar
• Katsuta M, Miyashita M, Makino H, Nomura T, Shinji S, Yamashita K, et al. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer. Exp Mol Pathol 2005; 78:123 - 130
   PubMed Web of Science ®Google Scholar
• Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996; 68:850 - 858
   PubMed Web of Science ®Google Scholar
• Kandasamy K, Pandey A, Molina H. Evaluation of several MS/MS search algorithms for analysis of spectra derived from electron transfer dissociation experiments. Anal Chem 2009; 81:7170 - 7180
   PubMed Web of Science ®Google Scholar
• Prasad TS, Kandasamy K, Pandey A. Human protein reference database and human proteinpedia as discovery tools for systems biology. Methods Mol Biol 2009; 577:67 - 79
   PubMedGoogle Scholar
• Kashyap MK, Marimuthu A, Peri S, Kumar GSS, Jacob HCK, Prasad TSK, et al. Overexpression of periostin and lumican in esophageal squamous cell carcinoma. Cancers 2010; 2:133 - 142
   PubMedGoogle Scholar
• Peri S, Navarro JD, Kristiansen TZ, Amanchy R, Surendranath V, Muthusamy B, et al. Human protein reference database as a discovery resource for proteomics. Nucleic Acids Res 2004; 32:497 - 501
   PubMed Web of Science ®Google Scholar
• Kandasamy K, Keerthikumar S, Goel R, Mathivanan S, Patankar N, Shafreen B, et al. Human proteinpedia: a unified discovery resource for proteomics research. Nucleic Acids Res 2009; 37:773 - 781
   PubMed Web of Science ®Google Scholar
• Kashyap MK, Marimuthu A, Kishore CJ, Peri S, Keerthikumar S, Prasad TS, et al. Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers. Cancer Biol Ther 2009; 8:36 - 46
   PubMed Web of Science ®Google Scholar
• Wada S, Noguchi T, Takeno S, Kawahara K. PIK3CA and TFRC located in 3q are new prognostic factors in esophageal squamous cell carcinoma. Ann Surg Oncol 2006; 13:961 - 966
   PubMed Web of Science ®Google Scholar
• Tsukita S, Yonemura S. Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins. J Biol Chem 1999; 274:34507 - 34510
   PubMed Web of Science ®Google Scholar
• Gao SY, Li EM, Cui L, Lu XF, Meng LY, Yuan HM, et al. Sp1 and AP-1 regulate expression of the human gene VIL2 in esophageal carcinoma cells. J Biol Chem 2009; 284:7995 - 8004
   PubMed Web of Science ®Google Scholar
• Xie JJ, Xu LY, Xie YM, Zhang HH, Cai WJ, Zhou F, et al. Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells. Int J Cancer 2009; 124:2549 - 2558
   PubMed Web of Science ®Google Scholar
• Zeng H, Xu L, Xiao D, Zhang H, Wu X, Zheng R, et al. Altered expression of ezrin in esophageal squamous cell carcinoma. J Histochem Cytochem 2006; 54:889 - 896
   PubMed Web of Science ®Google Scholar
• Chen JH, Chen LM, Xu LY, Wu MY, Shen ZY. Expression and significance of heat shock proteins in esophageal squamous cell carcinoma. Zhonghua Zhong Liu Za Zhi 2006; 28:758 - 761
   PubMedGoogle Scholar
• Faried A, Sohda M, Nakajima M, Miyazaki T, Kato H, Kuwano H. Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma. Eur J Cancer 2004; 40:2804 - 2811
   PubMed Web of Science ®Google Scholar
• Fernandez CA, Yan L, Louis G, Yang J, Kutok JL, Moses MA. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res 2005; 11:5390 - 5395
   PubMed Web of Science ®Google Scholar
• Zhang H, Xu L, Xiao D, Xie J, Zeng H, Wang Z, et al. Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion. J Clin Pathol 2007; 60:555 - 561
   PubMed Web of Science ®Google Scholar
• Cui L, Xu LY, Shen ZY, Tao Q, Gao SY, Lv Z, et al. NGALR is overexpressed and regulated by hypomethylation in esophageal squamous cell carcinoma. Clin Cancer Res 2008; 14:7674 - 7681
   PubMed Web of Science ®Google Scholar
• Srisomsap C, Sawangareetrakul P, Subhasitanont P, Chokchaichamnankit D, Chiablaem K, Bhudhisawasdi V, et al. Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes. J Biomed Biotechnol 2010; 437143
   PubMedGoogle Scholar
• Berchem G, Glondu M, Gleizes M, Brouillet JP, Vignon F, Garcia M, Liaudet-Coopman E. Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene 2002; 21:5951 - 5955
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen J, Meng L, Liu J, Du D, Zou Y. [A histopathologic and immunohistochemical study of prognostic factors in esophageal squamous cell carcinoma]. Zhonghua Bing Li Xue Za Zhi 2000; 29:267 - 271
   PubMedGoogle Scholar
• Wu N, Zhang W, Yang Y, Liang YL, Wang LY, Jin JW, et al. Profilin 1 obtained by proteomic analysis in all-trans retinoic acid-treated hepatocarcinoma cell lines is involved in inhibition of cell proliferation and migration. Proteomics 2006; 6:6095 - 6106
   PubMed Web of Science ®Google Scholar
• Braun M, Fountoulakis M, Papadopoulou A, Vougas K, Seidel I, Holler T, et al. Downregulation of microfilamental network-associated proteins in leukocytes of breast cancer patients: potential application to predictive diagnosis. Cancer Genomics Proteomics 2009; 6:31 - 40
   PubMedGoogle Scholar
• Lioni M, Noma K, Snyder A, Klein-Szanto A, Diehl JA, Rustgi AK, et al. Bortezomib induces apoptosis in esophageal squamous cell carcinoma cells through activation of the p38 mitogen-activated protein kinase pathway. Mol Cancer Ther 2008; 7:2866 - 2875
   PubMed Web of Science ®Google Scholar
• Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 2001; 276:42462 - 42467
   PubMed Web of Science ®Google Scholar
• Ralhan R, Desouza LV, Matta A, Chandra Tripathi S, Ghanny S, Dattagupta S, et al. iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy. J Proteome Res 2009; 8:300 - 309
   PubMed Web of Science ®Google Scholar
• Lin M, Morrison CD, Jones S, Mohamed N, Bacher J, Plass C. Copy number gain and oncogenic activity of YWHAZ/14-3-3zeta in head and neck squamous cell carcinoma. Int J Cancer 2009; 125:603 - 611
   PubMed Web of Science ®Google Scholar
• Heidenblad M, Lindgren D, Jonson T, Liedberg F, Veerla S, Chebil G, et al. Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors. BMC Med Genomics 2008; 1:3
   PubMed Web of Science ®Google Scholar
• van der Watt PJ, Maske CP, Hendricks DT, Parker MI, Denny L, Govender D, et al. The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation. Int J Cancer 2009; 124:1829 - 1840
   PubMed Web of Science ®Google Scholar
• Kau TR, Way JC, Silver PA. Nuclear transport and cancer: from mechanism to intervention. Nat Rev Cancer 2004; 4:106 - 117
   PubMed Web of Science ®Google Scholar
• Monitto CL, Dong SM, Jen J, Sidransky D. Characterization of a human homologue of proteolysisinducing factor and its role in cancer cachexia. Clin Cancer Res 2004; 10:5862 - 5869
   PubMed Web of Science ®Google Scholar
• Porter D, Weremowicz S, Chin K, Seth P, Keshaviah A, Lahti-Domenici J, et al. A neural survival factor is a candidate oncogene in breast cancer. Proc Natl Acad Sci USA 2003; 100:10931 - 10936
   PubMed Web of Science ®Google Scholar
• Stewart GD, Skipworth RJ, Ross JA, Fearon K, Baracos VE. The dermcidin gene in cancer: role in cachexia, carcinogenesis and tumour cell survival. Curr Opin Clin Nutr Metab Care 2008; 11:208 - 213
   PubMed Web of Science ®Google Scholar
• Zhou ZQ, Cao WH, Xie JJ, Lin J, Shen ZY, Zhang QY, et al. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer 2009; 9:291
   PubMed Web of Science ®Google Scholar
• Gubern C, Hurtado O, Rodriguez R, Morales JR, Romera VG, Moro MA, et al. Validation of housekeeping genes for quantitative real-time PCR in in-vivo and in-vitro models of cerebral ischaemia. BMC Mol Biol 2009; 10:57
   PubMed Web of Science ®Google Scholar
• Yu KD, Fan L, Di GH, Yuan WT, Zheng Y, Huang W, et al. Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1. Breast Cancer Res Treat 2010; 121:485 - 496
   PubMed Web of Science ®Google Scholar
• Skonier J, Neubauer M, Madisen L, Bennett K, Plowman GD, Purchio AF. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol 1992; 11:511 - 522
   PubMed Web of Science ®Google Scholar
• Shah JN, Shao G, Hei TK, Zhao Y. Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR. BMC Cancer 2008; 8:284
   PubMed Web of Science ®Google Scholar
• Wong FH, Huang CY, Su LJ, Wu YC, Lin YS, Hsia JY, et al. Combination of microarray profiling and proteinprotein interaction databases delineates the minimal discriminators as a metastasis network for esophageal squamous cell carcinoma. Int J Oncol 2009; 34:117 - 128
   PubMed Web of Science ®Google Scholar
• Teramoto R, Minagawa H, Honda M, Miyazaki K, Tabuse Y, Kamijo K, et al. Protein expression profile characteristic to hepatocellular carcinoma revealed by 2D-DIGE with supervised learning. Biochim Biophys Acta 2008; 1784:764 - 772
   PubMed Web of Science ®Google Scholar
• Ullrich A, Sures I, D'Egidio M, Jallal B, Powell TJ, Herbst R, et al. The secreted tumor-associated antigen 90K is a potent immune stimulator. J Biol Chem 1994; 269:18401 - 18407
   PubMed Web of Science ®Google Scholar
• Calabrese G, Sures I, Pompetti F, Natoli G, Palka G, Iacobelli S. The gene (LGALS3BP) encoding the serum protein 90K, associated with cancer and infection by the human immunodeficiency virus, maps at 17q25. Cytogenet Cell Genet 1995; 69:223 - 225
   PubMedGoogle Scholar
• Iacobelli S, Sismondi P, Giai M, D'Egidio M, Tinari N, Amatetti C, et al. Prognostic value of a novel circulating serum 90K antigen in breast cancer. Br J Cancer 1994; 69:172 - 176
   PubMed Web of Science ®Google Scholar
• Marchetti A, Tinari N, Buttitta F, Chella A, Angeletti CA, Sacco R, et al. Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients. Cancer Res 2002; 62:2535 - 2539
   PubMed Web of Science ®Google Scholar
• Ulmer TA, Keeler V, Loh L, Chibbar R, Torlakovic E, Andre S, et al. Tumor-associated antigen 90K/Mac-2-binding protein: possible role in colon cancer. J Cell Biochem 2006; 98:1351 - 1366
   PubMed Web of Science ®Google Scholar
• Scambia G, Panici PB, Baiocchi G, Perrone L, Iacobelli S, Mancuso S. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer. Anticancer Res 1988; 8:761 - 764
   PubMed Web of Science ®Google Scholar
• Zhang DS, Jiang WQ, Li S, Zhang XS, Mao H, Chen XQ, et al. Predictive significance of serum 90K/Mac-2BP on chemotherapy response in non-Hodgkin's lymphoma. Ai Zheng 2003; 22:870 - 873
   PubMedGoogle Scholar
• Park YP, Choi SC, Kim JH, Song EY, Kim JW, Yoon DY, et al. Upregulation of Mac-2 binding protein by hTERT in gastric cancer. Int J Cancer 2007; 120:813 - 820
   PubMed Web of Science ®Google Scholar
• Chinni SR, Brenz M, Shisheva A. Modulation of GDP-dissociation inhibitor protein membrane retention by the cellular redox state in adipocytes. Exp Cell Res 1998; 242:373 - 380
   PubMed Web of Science ®Google Scholar
• Speicher MR, Howe C, Crotty P, du Manoir S, Costa J, Ward DC. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 1995; 55:1010 - 1013
   PubMed Web of Science ®Google Scholar
• Sun ZL, Zhu Y, Wang FQ, Chen R, Peng T, Fan ZN, et al. Serum proteomic-based analysis of pancreatic carcinoma for the identification of potential cancer biomarkers. Biochim Biophys Acta 2007; 1774:764 - 771
   PubMed Web of Science ®Google Scholar
• Zhang LY, Ying WT, Mao YS, He HZ, Liu Y, Wang HX, et al. Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches. World J Gastroenterol 2003; 9:650 - 654
   PubMed Web of Science ®Google Scholar
• Qi Y, Chiu JF, Wang L, Kwong DL, He QY. Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics 2005; 5:2960 - 2971
   PubMed Web of Science ®Google Scholar
• Wang SJ, Zhang LW, Yu WF, Yu JK, Zheng S, Li YS, et al. Establishment of a diagnostic model of serum protein fingerprint pattern for esophageal cancer screening in high incidence area and its clinical value. Zhonghua Zhong Liu Za Zhi 2007; 29:441 - 443
   PubMedGoogle Scholar
• Liu WL, Zhang G, Wang JY, Cao JY, Guo XZ, Xu LH, et al. Proteomics-based identification of autoantibody against CDC25B as a novel serum marker in esophageal squamous cell carcinoma. Biochem Biophys Res Commun 2008; 375:440 - 445
   PubMed Web of Science ®Google Scholar
• Shao CCS, Chen L, Cobos E, Wang J, Haab BB, Gao W. Antibody microarray analysis of serum glycans in esophageal squamous cell carcinoma cases and controls. Proteomics Clin Appl 2009; 3:923 - 931
   PubMed Web of Science ®Google Scholar
• Hoshino I, Matsubara H, Akutsu Y, Nishimori T, Yoneyama Y, Murakami K, et al. Gene expression profiling induced by histone deacetylase inhibitor, FK228, in human esophageal squamous cancer cells. Oncol Rep 2007; 18:585 - 592
   PubMed Web of Science ®Google Scholar
• Gu ZD, Li JY, Li M, Gu J, Shi XT, Ke Y, Chen KN. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma. Am J Gastroenterol 2005; 100:1835 - 1843
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Tomita Y, Hoshida Y, Iizuka N, Kidogami S, Miyata H, et al. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma. Clin Cancer Res 2004; 10:5558 - 5565
   PubMed Web of Science ®Google Scholar
• Wu X, Wanders A, Wardega P, Tinge B, Gedda L, Bergstrom S, et al. Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin. Br J Cancer 2009; 100:334 - 343
   PubMed Web of Science ®Google Scholar